相关实验视频

Updated: Jun 25, 2025

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

对HER2-表达性癌症的亲体PET成像作为指导HER2-向治疗的关键

Nina Eissler¹, Renske Altena^2,3,4, Ali Alhuseinalkhudhur^5,6

¹Affibody AB, 17165 Solna, Sweden.

|May 25, 2024

概括

用HER2-Affibody放射追踪器进行分子成像提供了一种非侵入性方法,以确定符合HER2-向新疗法的乳腺癌患者. 这种方法克服了传统活检的局限性,用于准确的患者选择.

科学领域:

在瘤学瘤学.
放射化学放射化学是指辐射化学.
分子成像学分子成像学

背景情况:

人类表皮生长因子受体2 (HER2) 是15-20%的乳腺癌的关键标记物,指导向治疗.
新的治疗方法,如trastuzumab deruxte,可以扩大HER2表达率较低的患者的资格,需要改进诊断.
目前基于活检的方法具有侵入性,限制重复评估,并且无法捕捉瘤异质性,导致误诊.

研究的目的:

审查目前的HER2向治疗场景.
讨论使用放射追踪剂进行HER2分子成像的临床实用性和可行性.
介绍关于基于HER2-Affibody的分子成像作为乳腺癌诊断工具的数据.

主要方法:

对HER2向疗法和诊断景观的审查.
描述使用HER2成像诊断的经验.
对基于HER2-Affibody的分子成像的临床数据的分析.

主要成果:

HER2-Affibody分子是小型的工程蛋白质 (约6.5kDa),具有用于分子成像的验证特征.
用射线追踪器进行分子成像,为侵入性活检诊断提供了一个高度准确的替代方案.
临床数据支持基于HER2-Affibody的成像的实用性.

结论:

基于HER2-Affibody的分子成像是一种有前途的乳腺癌新型诊断工具.
这种成像模式可以可靠地识别符合HER2向治疗的患者,包括具有低HER2表达的患者.
它通过提供非侵入性和全面的评估来解决基于活检的诊断的局限性.

关键词:

附带体分子的分子.在HER2中,HER2是HER2.乳腺癌乳腺癌乳腺癌临床试验是指临床试验中的临床试验.诊断诊断诊断诊断诊断分子成像分子成像技术

更多相关视频

Determining Binding Affinity KD of Radiolabeled Antibodies to Immobilized Antigens

Determining Binding Affinity KD of Radiolabeled Antibodies to Immobilized Antigens

Published on: June 23, 2022

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Gene Regulation and Targeted Therapy in Gastric Cancer Peritoneal Metastasis: Radiological Findings from Dual Energy CT and PET/CT

Published on: January 22, 2018

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Imaging Studies II: Positron Emission Tomography and Scintigraphy

Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...